Atraverse wins FDA nod for left-heart access device
May 15, 2024
Atraverse Medical announced today that the FDA cleared its Hotwire radiofrequency guidewire left-heart access device.
Atraverse Medical announced today that the FDA cleared its Hotwire radiofrequency guidewire left-heart access device.
SAN JOSE, Calif., May 13, 2024 /PRNewswire/ — Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy System. With this significant milestone achieved, Meditrina is thrilled to enter international markets, marking a pivotal moment in the company’s commitment to advancing women’s health globally.
The procedures utilized an AI-powered, robotic TIGERTRIEVER to automate and optimize personalized treatments
IRVINE, Calif., May 14, 2024 /PRNewswire/ — OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, in Japan. The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and supported over 68,000 OrthAlign cases.
The microArch D1025 Dual-Resolution 3D printer delivers the additive manufacture of parts that require micron-level precision and repeatability, with potential uses in the healthcare and life sciences fields.
Profound Medical (Nasdaq:PROF) announced today that it received FDA 510(k) clearance for its second AI model for treating prostate cancer.
The FDA has warned that home test users, caregivers and healthcare providers should not use Cue Health COVID-19 diagnostics.
Carthera announced today that it received FDA and European orphan drug designation (ODD) for the use of carboplatin with its SonoCloud.
CENTER VALLEY, Pa., May 13, 2024 /PRNewswire/ — Olympus, a global medical technology company, announced today the launch of two bronchoscopes as part of the EVIS X1 Endoscopy System. The EVIS X1 Endoscopy System represents the latest in diagnostic and therapeutic bronchoscopy from Olympus.
Medtronic (NYSE: MDT)+
announced today that its PulseSelect pulsed field ablation (PFA) system has won regulatory approval in Japan.